Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JGPMA Proposes “Drug Benefit Standard Price” System
June 25, 2007
- Pfizer Most Active in GP Market: MOSS Survey
June 25, 2007
- GENERIC NEWS IN BRIEF
June 25, 2007
- BUSINESS NEWS IN BRIEF
June 25, 2007
- MEDICAL DEVICE NEWS IN BRIEF
June 25, 2007
- NEW PRODUCTS
June 25, 2007
- Hemorrhoid Recurrence Rate 16% 1 Year after Zione Treatment
June 25, 2007
- Monthly Pay Raise Averages \6,627 for 8 Pharma Companies
June 18, 2007
- Consensus Not Reached on the Need for Practical Experience: Exam for Drug Salespersons
June 18, 2007
- Diovan Recaptures Top Position in April
June 18, 2007
- Acute Stage Rehabilitation Important: Korosho
June 18, 2007
- BUSINESS NEWS IN BRIEF
June 18, 2007
- Arixtra Should Promote Awareness of VTE: GSK
June 18, 2007
- Mr Sawai Responds to Criticisms
June 18, 2007
- JPA Concerned about Excess of Pharmacists
June 18, 2007
- GENERIC NEWS IN BRIEF
June 18, 2007
- WG Inaugurated to Predict Demand & Supply for Pharmacists
June 18, 2007
- 28 Drugs (13 APIs) Included in NHI Price List
June 18, 2007
- Sales of 23 TSE Section 1 Companies Up 2.2%
June 18, 2007
- 77 Applications for New Drugs Approved in FY2006: PMDA
June 18, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…